What the company does
Hypera S.A. operates as a pharmaceutical company in Brazil. The company provides sweeteners products under the Adocyl, finn, and Zero-cal brands; analgesics and anti-inflammatories products under the Doril, Atroveran, Calminex, Alivium, Buscopan, Buscofem, geloll, Torsilax, Neosaldina, and naprohax brands; cold and flu remedies and decongestants products under BENEGRIO, Rinosoro, Blu, Neosoro, Coristina, APRACUR, and Fluviral brands. It offers antihistamines products under Alektos, Histamin, Polaramine, PredSim, and Desrinite brands; antiseptics products under Merthiolate brand; Herbal medicine products under Maracugina, Eparema, Tamarine, and Naturetti brands; gastrointestinal products under Dramin, Estomazil, Engov, Lacto-purga, gastrol, Epocler, Bifilax, and Pepsamar …
What the weekly tape is saying
HYPE3 closed the latest completed week at 21.49 BRL. The 4-week return is -6.7% and the 12-week return is -1.8%. Trend Signal is inactive, Market Dynamics is -0.51. Setup signature: Risk-first tape with a 21/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 23.04 BRL
- Vs Trend Line
- -6.7%
- Fair Value
- 25.56 BRL
- Vs Fair Value
- -15.9%
- 52W High
- 27.54 BRL
- 52W Low
- 20.17 BRL
- Drawdown
- -22.0%
- Range Position
- 17.9%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 18
- 52W Active Breadth
- 34.6%
- Sector Scope
- BR Healthcare
- Sector Rank
- 24 of 80
- Sector Percentile
- 70.9%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
BR Healthcare
- Tracked Peers
- 80
- 4W Rank
- 66 of 80
- Avg 1W
- 1.2%
- Avg 4W
- 3.5%
- Trend Breadth
- 20.0%
- Positive MD
- 31.3%
BR Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 9
- 4W Rank
- 7 of 9
- Avg 1W
- 0.6%
- Avg 4W
- -1.0%
- Trend Breadth
- 44.4%
- Positive RS
- 44.4%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.51
- 4W MD Change
- -978.2%
- Relative Strength
- -14.73
- 4W RS Change
- -3.5%
- Expectation
- Undecided
- Probability
- 47.15%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 11.1M
- 13W Average
- 16.6M
- 52W Average
- 14.1M
- Vs 13W
- 0.7x
- Vs 52W
- 0.8x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 2.9%
- 52W Volatility
- 4.0%
- Upside Weeks
- 21
- Downside Weeks
- 31
- Downside Breadth
- 59.6%
- Avg Gain / Loss
- 3.6% / -3.0%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- SAO
- Country
- BR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- BRL
- Market Cap
- 15.1B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 21.49 BRL | 2.4% | 23.04 BRL | 25.56 BRL | -0.51 | -14.73 | 11.1M | Off |
| 5 Jun 2026 | 20.98 BRL | -4.2% | 23.15 BRL | 25.68 BRL | -0.20 | -16.45 | 13.8M | Off |
| 29 May 2026 | 21.91 BRL | -2.9% | 23.26 BRL | 25.80 BRL | 0.15 | -15.78 | 8.4M | Off |
| 22 May 2026 | 22.56 BRL | -2.0% | 23.37 BRL | 25.90 BRL | 0.19 | -15.03 | 11.1M | Off |
| 15 May 2026 | 23.03 BRL | -1.4% | 23.39 BRL | 25.98 BRL | 0.06 | -14.23 | 33.1M | Off |
| 8 May 2026 | 23.36 BRL | 3.7% | 23.34 BRL | 26.06 BRL | -0.08 | -16.66 | 29.9M | Off |
| 1 May 2026 | 22.53 BRL | -0.0% | 23.25 BRL | 26.12 BRL | -0.16 | -21.34 | 18.6M | Off |
| 24 Apr 2026 | 22.54 BRL | -3.9% | 23.23 BRL | 26.19 BRL | -0.21 | -23.12 | 6.1M | Off |
| 17 Apr 2026 | 23.45 BRL | 0.3% | 23.22 BRL | 26.25 BRL | -0.27 | -22.56 | 18.6M | Off |
| 10 Apr 2026 | 23.39 BRL | 1.7% | 23.21 BRL | 26.31 BRL | -0.47 | -23.64 | 21.1M | Off |
| 3 Apr 2026 | 22.99 BRL | 5.0% | 23.17 BRL | 26.37 BRL | -0.82 | -21.50 | 10.1M | Off |
| 27 Mar 2026 | 21.90 BRL | 0.0% | 23.16 BRL | 26.44 BRL | -0.94 | -22.83 | 13.3M | Off |
| 20 Mar 2026 | 21.89 BRL | 3.4% | 23.21 BRL | 26.51 BRL | -0.91 | -20.75 | 20.8M | Off |
| 13 Mar 2026 | 21.18 BRL | -2.6% | 23.25 BRL | 26.59 BRL | -0.94 | -24.14 | 16.9M | Off |